Presentations

2009

Barranco JB, Reyes EL, Francis JL. Evaluation of an Alternate Activating Reagent for the Performance of Coagulation Factors in the Presence of Lupus Anticoagulants. Mayo Clinic Coagulation testing Quality Conference and Workshop. Minneapolis, MN, April 13-15, 2009.

Mousa SA, Phillips PG, Yalcin M, Borsig L, Amirkhosravi M, Francis JL and Sehgal L. Direct anti-cancer efficacy of heparin and heparin-derived compounds independent from its anticoagulant activity. American Society of Clinical Oncology, Orlando, FL, May 29 - June 2, 2009.

Hatfield ML, Meyer J, Robles-Carillo L, Amirkhosravi A, Meyer T, Francis JL. Platelet surface binding enhances immune complex-induced platelet aggregation. International Society for Thrombosis and Hemostasis, Boston July 11-6, 2009.

Coll E, Amirkhosravi A, Francis JL. Detection of tissue factor activity in whole blood by a fluorogenic thrombin generation assay. International Society for Thrombosis and Hemostasis, Boston July 11-6, 2009.

Amirkhosravi A, Meyer T, Desai H, Davila M, Langer F, Amaya M and Francis JL. Platelet activation and thrombosis by anti-CD40L immune complexes. International Society for Thrombosis and Hemostasis, Boston July 11-6, 2009.

Davila M, Amirkhosravi A, Baker CH and Francis JL. Tumor cell-derived microparticles: does size matter? International Society for Thrombosis and Hemostasis, Boston July 11-6, 2009.

Amirkhosravi A, Bigsby IV G, Coll E, Desai H, Amaya M, Robles L, Faust L, Drexler A, Langer F, Reyes E and Francis JL. A prospective analysis of plasma tissue factor in patients with ovarian tumors. International Society for Thrombosis and Hemostasis, Boston July 11-6, 2009.

Spath B, Amirkhosravi A, Francis JL, Bokemeyer C, Eifrig B, Langer F. Role of tissue factor (TF) in leukemia-associated coagulation activation and VEGF expression. International Society for Thrombosis and Hemostasis, Boston July 11-6, 2009.

Moffat KA, Plumhoff E, Reyes E, Hoffman S, Israels S, Meijer P, and Hayward CPM. Pilot Proficiency Exercise for the Interpretation of Light Transmittance Platelet Aggregations - Results from an International Challenge. International Society for Thrombosis and Hemostasis, Boston July 11-6, 2009.

Hayward CP, Moffat KA, Plumhoff E, Meijer P, Spitzer E, Timleck M, Israels SJ, White J, Reyes E, Hoffman S, on behalf of the NASCOLA Working Group on Platelet Disorders. NASCOLA / ECAT Platelet Aggregometry Interpretive Survey and Proficiency Exercise for Dense Granule Deficiency Evaluation. International Society for Thrombosis and Hemostasis, Boston July 11-6, 2009.

2008

Coll-Sangrona E, Amirkhosravi A, Davila M, Amaya M, Desai H, Robles L and Francis JL. Thrombin generation assay in the study of the procoagulant activity of cancer cells and the microparticles derived from them. XX Latin American Congress of Thrombosis and Hemostasis - VIII Argentinean Congress of Thrombosis and Hemostasis, Buenos Aires. April 23-26, 2008.

Amirkhosravi A, Meyer TV, Robles-Carillo L, Langer F, Robson T, Desai H, Davila M, Amaya M and Francis JL. Bevacizumab immune complexes induce thrombocytopenia and thrombosis in mice transgenic for human IgG receptor FcgammaRIIa. American Society for Hematology Annual Meeting, San Francisco, CA, December 2008.

Amirkhosravi A, Meyer TV, Robles-Carillo L, Davila M, Langer F, Desai H, Weinstein P, Amaya M and Francis JL. Mechanism of thrombocytopenia induced by Anti-CD40 Ligand immune complexes and the prevalence of CD40 Ligand autoantibodies in patients with thrombotic autoimmune disorders. American Society for Hematology Annual Meeting, San Francisco, CA, December 2008.

Haubold K, Rink M, Spath B, Amirkhosravi A, Francis JL, and Eifrig B. Microparticle-associated tissue factor: A molecular link between coagulation activation, inflammation and disease progression in early stage prostate cancer. American Society for Hematology Annual Meeting, San Francisco, CA, December 2008.

2007

Davila M, Meyer T, Langer F, Robson T, Robles L, Desai A, Amirkhosravi A, Amaya M, Elias P and Francis JL. Therapeutic antibodies against CD40 ligand, TNF-alpha and VEGF share mechanistic features in common with platelet activating antibodies in heparin-induced thrombocytopenia (HIT). International Society for Thrombosis and Haemostasis, Geneva, Switzerland, July 6-12, 2007.

Amirkhosravi A, Langer F, Ingersoll SB, Robson T and Francis JL. Blood-borne, but not endothelial CD40 promotes experimental lung metastasis. International Society for Thrombosis and Haemostasis, Geneva, Switzerland, July 6-12, 2007.

Davila M, Amirkhosravi A, Coll E, Robles L, Baker M, Abdelrahim M, Colon J and Francis JL. Impact of tissue factor bearing microparticles derived from tumor cells on coagulation activation. International Society for Thrombosis and Haemostasis, Geneva, Switzerland, July 6-12, 2007.

Francis JL, Bigsby G, Desai H, Amaya M, Coll E, Robles L, Drexler A, Faust P, Langer F, Reyes E and Amirkhosravi A. Hypercoagulability in ovarian cancer revisited. A prospective analysis of coagulation and platelet activation markers. International Society for Thrombosis and Haemostasis, Geneva, Switzerland, July 6-12, 2007.

Mousa S, Johansen KB, Francis JL and Amirkhosravi A. Anti-metastatic activity of low molecular weight heparin in experimental metastasis model. International Society for Thrombosis and Haemostasis, Geneva, Switzerland, July 6-12, 2007.

Francis JL, Drexler A, Duncan M, Desai H, Amaya M, Robson T, Meyer TV, Reyes E and Amirkhosravi A. Prospective evaluation of laboratory tests for the diagnosis of heparin-induced thrombocytopenia. International Society for Thrombosis and Haemostasis, Geneva, Switzerland, July 6-12, 2007.

Francis JL, Drexler A, Duncan A Desai H, Amaya M, Robson T, Meyer TV, Reyes E and Amirkhosravi A. Performance of the PIFA test for anti-PF4/H antibodies in a prospective study of patients with suspected HIT. Platelet Immunology Scientific Subcommittee, International Society for Thrombosis and Haemostasis, Geneva, Switzerland, July 6-12, 2007.

Francis JL, Drexler A, Duncan A Desai H, Amaya M, Robson T, Meyer TV, Reyes E and Amirkhosravi A. Diagnostic utility of high concentrations of heparin in "confirming" a positive EIA. Platelet Immunology Scientific Subcommittee, International Society for Thrombosis and Haemostasis, Geneva, Switzerland, July 6-12, 2007.

Drexler A. Translation of Research into Practice: Making it Happen. Sigma Theta Tau International: Theta Epsilon Chapter (Honor Society for Nursing) Panel Discussion member. Winter Park, FL, April 3, 2007.

Drexler A. The Bottom Line: Impact of Protocol Feasibility. 2007 Association of Clinical Research Professionals (ACRP) Global Conference & Exhibition. Seattle, WA, April 23, 2007.

Drexler A. The Bottom Line: Impact of Protocol Feasibility. Baltimore/Washington Chapter of the ACRP. 5th Annual Symposium - Excellence in Research: Building a Strong Foundation. September 21, 2007.

Coll-Sangrona E, Amirkhosravi A, Lalani, AS, Robles L, Desai H, Amaya M and Francis JL. High-dose calcitriol modulates the expression and activity of tissue factor and thrombomodulin in tumor cells. American Society for Hematology Annual Meeting, Atlanta, GA, December 2007.

2006

Francis JL, Drexler A, Duncan MK, Desai H, Amaya M, Robson, M.T. Meyer TV, Reyes E and Amirkhosravi A. Prospective evaluation of laboratory tests for the diagnosis of heparin-induced thrombocytopenia. 19th International Congress on Thrombosis, Tel Aviv, Israel, May 15-19, 2006.

Davila M, Amirkhosravi A, Meyer TV, Langer F, Reyes E and Francis JL. Antibodies to CD40 ligand aggregate platelets and may occur in patients with antiphospholipid syndrome. 19th International Congress on Thrombosis, Tel Aviv, Israel, May 15-19, 2006.

Davila M, Coll E, Amirkhosravi A, Francis JL. Tumor cell-derived microparticles and tissue factor: implications for clotting activation in cancer. 19th International Congress on Thrombosis, Tel Aviv, Israel, May 15-19, 2006.

Levine RL, Hergenroeder GW and Francis JL. Prevalence of Heparin-Platelet Factor 4 Antibodies in Surgical and Medical Intensive Care Units. CHEST 2006, Salt Lake City, October 21-26, 2006.

Davila M, Amirkhosravi A, Coll E, Robles L, Francis JL. Tissue factor-bearing microparticles derived from tumor cells: Impact on coagulation activation. American Society for Hematology, Orlando, December 2006.

Amirkhosravi A, Ingersoll S, Robson T, Langer F, Walker J and Francis JL. The role of platelet CD40 in hematogenous experimental metastasis. American Society for Hematology, Orlando, December 2006.

Amirkhosravi A, Bigsby IV, G, Desai H, Amaya M1, Coll E, Robles L, Drexler A, Langer F, Francis JL. Hypercoagulability in ovarian cancer revisited: a prospective analysis of coagulation and platelet activation markers. American Society for Hematology, Orlando, December 2006.

Meyer T, Amirkhosravi A, Robson T, Amaya M, Desai H, Su L, Hsu Y-M, Langer F, Francis JL. Platelet activation by anti-CD40 ligand antibodies. American Society for Hematology, Orlando, December 2006.

Todd Meyer T, Robson T, Amirkhosravi A, Langer F, Desai H, Amaya M, Elias P and Francis JL. Targeting angiogenesis in cancer: bevacizumab-induced platelet activation as a possible cause for unexpected arterial thromboembolic events in clinical trials. American Society for Hematology, Orlando, December 2006.

Francis JL, Drexler A, Duncan MK, Desai H, Amaya M, Robson T, Meyer T, Reyes E and Amirkhosravi A. Prospective Evaluation of Laboratory Tests for the Diagnosis of Heparin-Induced Thrombocytopenia. American Society for Hematology, Orlando, December 2006.

2005

Ahmad S, Drexler A, Walker J, Reyes E, Meyer T and Francis JL. Bovine heparin generates significantly more functional heparin-PF4 antibodies than porcine heparin following cardiac surgery. First Annual National Meeting of the Association of Scientists of Indian Origin in America. San Antonio, TX, January 21-23, 2005.

Ahmad S, Amirkhosravi A, Walker JM, Desai H, Amaya M, Langer F, Francis JL. Cellular effects of heparin-PF4 antibodies and its relevance to the pathogenesis of heparin-induced thrombocytopenia. International Society on Thrombosis & Haemostasis XXth Congress. Sydney, Australia, August 6-12, 2005.

Ahmad S, Amirkhosravi A, Langer F, Desai H, Amaya M, Francis JL. Importance of pre-analytical variables in the measurement of platelet-derived microparticles. International Society on Thrombosis & Haemostasis XXth Congress. Sydney, Australia, August 6-12, 2005.

Amirkhosravi A, Ingersoll SB, Langer F, Walker J, Meyer T, Amaya M and Francis JL. Genetic Evidence that CD154 (CD40 Ligand) plays a pathophysiologic role in the systemic coagulopathy associated with murine models of experimental metastasis and endotoxemia. International Society on Thrombosis & Haemostasis XXth Congress. Sydney, Australia, August 6-12, 2005.

Francis JL, Drexler A, Walker J and Rathmann K. Heparin platelet factor 4 antibody formation in patients receiving bivalirudin or heparin for off-pump coronary artery bypass surgery. International Society on Thrombosis & Haemostasis XXth Congress. Sydney, Australia, August 6-12, 2005.

Francis JL, Drexler A, Walker J, Duncan MK, Ahmad S. Heparin-platelet factor 4 antibodies are common among recently hospitalized patients with acute coronary syndromes presenting to the emergency department. International Society on Thrombosis & Haemostasis XXth Congress. Sydney, Australia, August 6-12, 2005.

Francis JL, Drexler A, and Moroose R. Successful Use of Bivalirudin in the Treatment of Patients Suspected, or at Risk of, Heparin-Induced Thrombocytopenia. International Society on Thrombosis & Haemostasis XXth Congress. Sydney, Australia, August 6-12, 2005.

Langer F, Amirkhosravi A, Amaya M, Spath B, Eifrig B and Francis JL. Platelet microparticle (PMP) are increased in patients with localized prostate cancer and correlate with plasma tissue factor (TF) antigen. 49th Annual Meeting of the German Society for Thrombosis and Haemostasis, Mannheim, Germany, February 23-26, 2005.

Langer F, Amirkhosravi A, Walker J, Ingersoll S, Francis JL and Eifrig B. Experimental metastasis and tumor cell-induced coagulopathy in mice with hemophilia A. 49th Annual Meeting of the German Society for Thrombosis and Haemostasis, Mannheim, Germany, February 23-26, 2005.

Langer F, Spath B, Hansen A, Marx G, Amirkhosravi A, Francis JL, Eifrig B. Expression of platelet CD40 and CD 40 Ligand (CD40L) in ambulatory patients with unexplained bleeding tendency. 49th Annual Meeting of the German Society for Thrombosis and Haemostasis, Mannheim, Germany, February 23-26, 2005.

Langer F, Ingersoll S, Amirkhosravi A, Meyer T, Siddiqui F, Ahmad S, Walker J, Amaya M, Desai H and Francis JL. The CD40/CD40 ligand (CD40L) pathway plays a role in primary hemostasis and platelet function. 49th Annual Meeting of the German Society for Thrombosis and Haemostasis, Mannheim, Germany, February 23-26, 2005.

Langer F, Amirkhosravi A, Meyer T, Siddiqui F, Ahmad S, Walker J, Amaya M, Desai H and Francis JL. Experimental metastasis and tumor cell-induced coagulopathy in mice with hemophilia A and the effect of FVIII replacement therapy. International Society on Thrombosis & Haemostasis XXth Congress. Sydney, Australia, August 6-12, 2005.

Langer F, Ingersoll SB, Amirkhosravi A, Meyer T, Siddiqui FA, Ahmad, S, Walker JM, Amaya M and Francis JL. CD40 and CD40 Ligand (CD40L) in primary hemostasis and antibody-mediated platelet activation. International Society on Thrombosis & Haemostasis XXth Congress. Sydney, Australia, August 6-12, 2005.

Langer F, Amirkhosravi A, Amaya M, Spath B, Eifrig B and Francis JL. Platelet microparticles (PMP) are increased in patients with localized prostate cancer and correlate with plasma tissue factor (TF) antigen levels. International Society on Thrombosis & Haemostasis XXth Congress. Sydney, Australia, August 6-12, 2005.

Langer F, Chun KHF, Amirkhosravi A, Leuenroth S, Friedrich MG, Eifrig B, Huland H, Bokemeyer C, Francis JL. Plasma Tissue Factor (TF) Antigen, Cellular Microparticles, and Markers of Coagulation and Platelet Activation in Localized Prostate Cancer. American Society for Hematology, Atlanta, December 2005.

Levine RL, Hergenroeder GW, Miller CC III, Francis JL. Heparin antibodies in intensive care unit patients (HAICU). International Society on Thrombosis & Haemostasis XXth Congress. Sydney, Australia, August 6-12, 2005.

2004

Ahmad S, Amirkhosravi A, Walker JM, Desai H, Amaya M, Siddiqui FA, Francis JL. Functional Consequences of Cellular Interactions with Heparin-PF4 Antibodies in Heparin-Induced Thrombocytopenia. American Society for Hematology, San Diego, CA, December 4-7, 2004.

Francis JL, Drexler A, Walker J, Duncan MK, Ahmad A. Frequency of Heparin-Platelet Factor 4 Antibodies among Patients with Acute Coronary Syndromes Presenting to the Emergency Department. American Society for Hematology, San Diego, CA, December 4-7, 2004.

Francis JL, Drexler A, Walker J, Rathmann K The relationship between systemic anticoagulation during cardiac surgery and heparin platelet factor 4 antibody formation. American Society for Hematology, San Diego, CA, December 4-7, 2004.

Francis JL, Drexler A, Gwyn G, Moroose R. Successful Use of Bivalirudin in the Treatment of Patients Suspected, or at Risk of, Heparin-Induced Thrombocytopenia. American Society for Hematology, San Diego, CA, December 4-7, 2004.

Ingersoll SB, Amirkhosravi A, Langer F, Walker JM, Meyer TV, Amaya M, Francis JL. Genetic evidence that CD154 (CD40 ligand) plays a pathophysiologic role in the systemic coagulopathy associated with murine models of experimental metastasis and endotoxemia. American Society for Hematology, San Diego, CA, December 4-7, 2004.

Langer F, Ingersoll SB, Amirkhosravi A, Meyer TV, Siddiqui FA, Rocca S, Ahmad S, Walker JM, Amaya M, Desa H, Francis JL. The CD40/CD40 ligand (CD40L) pathway plays a role in primary hemostasis and platelet function. American Society for Hematology, San Diego, CA, December 4-7, 2004.

Langer F, Amirkhosravi A, Spath B, Meyer T, Eifrig, Fiedler W, Hossfeld DK, Francis JL. An in vitro study on the mechanisms of coagulation activation in acute myelogenous leukemia (AML): role of tissue factor (TF) regulation by calcium ionophore, chemotherapeutic agents and TNF- . 48th Annual Meeting of the German Society for Thrombosis and Haemostasis Research, Hamburg, February 25-28, 2004.

Langer F, Amirkhosravi A, Ingersoll S, Meyer T, Eifrig B, Francis JL. Deficiency for CD154 (CD40 ligand) protects against LPS-induced thrombocytopenia in a murine model of endotoxinemia. 48th Annual Meeting of the German Society for Thrombosis and Haemostasis Research, Hamburg, February 25-28, 2004.

Langer F, Chun KHF, Hansen A, Spath B, Friedrich MG, Haese A, Amirkhosravi A, Meyer T, Ingersoll S, Amaya M, Walker JM, Desai H, Francis JL, Eifrig B, Huland H, Hossfeld DK. Increased plasma levels of F1.2, PAP, D-dimer and TF in patients with localized prostate cancer. 48th Annual Meeting of the German Society for Thrombosis and Haemostasis Research, Hamburg, February 25-28, 2004.

Langer F., Amirkhosravi A, Meyer TV, Ingersoll, SB, Rocca S, Sidduqui FA, Ahmad S, Walker J, Amaya M, Francis JL. Evidence for a role of the CD40/CD40 ligand (CD40L) pathway in primary hemostasis and platelet function. American Heart Association Scientific Sessions, New Orleans, November 7-10, 2004.

Sandhu R, Dougherty J, Drexler A, Francis JL. Comparison of clinical outcomes in patients with heparin-induced thrombocytopenia treated with direct thrombin inhibitors. American Society for Hematology, San Diego, CA, December 4-7, 2004.

Siddiqui FA, Desai H, Amirkhosravi A, Siddiqui TF, Francis JL. Platelet derived microparticles enhance tissue factor expression and procoagulant activity on human malignant cells. American Association for Cancer Research 95th Annual Meeting, Orlando, FL, March 27-31, 2004.

2003

Ahmad A, Amirkhosravi A, Drexler A, Desai H, Amaya M, Siddiqui FA, Reyes E, Francis JL. Functional Anti-Heparin-PF4 Antibody-Mediated Platelet-Endothelial Interactions: Modulation of Tissue Factor Activity Involved in the HIT Pathogenesis. Experimental Biology-2003 (FASEB) Annual Meetings, Diego, CA, April 11-15, 2003. Read this abstract.

Ahmad S, Drexler A, Reyes E, Meyer TV, Palmer III, GJ, Moroose R and Francis JL. Bovine heparin results in higher generation of functional anti-heparin-PF4 antibodies than porcine heparin following coronary artery bypass surgery. International Society for Thrombosis and Hemostasis XIX Congress, Birmingham, UK, July 12-18, 2003.

Ahmad A, Amirkhosravi A, Drexler A, Desai H, Amaya M, Siddiqui F, Reyes E and Francis JL. Functional anti-heparin-PF4 antibody-mediated platelet-endothelial cell interactions: Modulation of tissue factor activity involved in the HIT pathogenesis. International Society for Thrombosis and Hemostasis XIX Congress, Birmingham, UK, July 12-18, 2003.

Ahmad S, Amirkhosravi A, Walker JM, Dorfman R, Amaya M, Desa D, Meyer T and Francis JL. Functional heparin-PF4 antibodies from patients with heparin-induced thrombocytopenia (HIT) cause platelet-monocyte aggregation: implications for the pathogenesis of HIT. American Society for Hematology, San Diego, CA, December 6-9, 2003.

Ahmad S, Walker JM, Barranco JP, Siddiqui FA and Francis JL. bivalirudin and other direct thrombin inhibitors modulate platelet activation by thrombin and factor Xa: Clinico-pharmacologic implications for the management of HIT. American Society for Hematology, San Diego, CA, December 6-9, 2003.

Ahmad S, Walker JM, Drexler A, Reyes E, Palmer, GJ III, Moroose R and Francis JL. Bovine heparin generates significantly more functional heparin-PF4 antibodies of the IgG subtype than porcine heparin following cardiac surgery. American Society for Hematology, San Diego, CA, December 6-9, 2003.

Amirkhosravi A, Amaya M, Walker JM, Biddinger R and Francis JL. Activated Protein C Inhibits Tumor Cell-Induced Coagulation Activation In Vivo and Suppresses Experimental Lung Metastasis. American Society for Hematology, San Diego, CA, December 6-9, 2003. Read this abstract.

Amirkhosravi A, Biggerstaff JP, Amaya M and Francis JL. Quantitative analysis of fibrin deposition in solid tumors: A potential marker for tumor vascular permeability. International Society for Thrombosis and Hemostasis XIX Congress, Birmingham, UK, July 12-18, 2003.

Amirkhosravi A, Meyer TV, Desai H, Sackel DJ, Amaya M, Biggerstaff JP, Wehling J, Biddinger R and Francis JL. Platelet microparticles carry CD40 ligand and upregulate TF and VEGF in endothelial and melanoma cells: possible role in angiogenesis and metastasis. International Society for Thrombosis and Hemostasis XIX Congress, Birmingham, UK, July 12-18, 2003.

Blaydes Ingersoll S, Amirkhosravi A, Amaya M, Meyer T, Desai H, and Francis JL. Platelet CD40L and CD40 Enhance Tumor Cell-Induced Coagulopathy and Experimental Metastasis. AACR Special Conference: Mouse Models of Cancer, Orlando, FL. February 20-23, 2003. Read this abstract.

Francis JL, Drexler A, Gwyn G and Moroose R. Bivalirudin, a direct thrombin inhibitor, in the treatment of heparin-induced thrombocytopenia. International Society for Thrombosis and Hemostasis XIX Congress, Birmingham, UK, July 12-18, 2003.

Francis JL, Drexler A, Gwyn G and Moroose, R. Bivalirudin, a direct thrombin inhibitor, is a safe and effective treatment for heparin-induced thrombocytopenia. American Society for Hematology, San Diego, CA, December 6-9, 2003. Read this abstract.

Francis JL, Drexler A, Walker J, Duncan MK, Seabrun J and Ahmad S. Frequency of heparin-platelet factor 4 antibodies in patients presenting to the emergency department with symptoms of thrombosis. American Heart Association Scientific Sessions, Orlando, November 9-12, 2003. Read this abstract.

Francis JL, Drexler A, Walker J, Duncan MK, and Ahmad SA Frequency of Heparin-Platelet Factor 4 antibodies in patients presenting to the Emergency Department with symptoms of thrombosis. American Society for Hematology, San Diego, CA, December 6-9, 2003. Read this abstract.

Francis JL and Drexler A. Frequency of Heparin-Platelet Factor 4 Antibodies in patients Presenting to the Emergency Room with Symptoms of Thrombosis. International Society for Thrombosis and Hemostasis XIX Congress, Birmingham, UK, July 12-18, 2003.

Francis JL and Drexler A. The importance of repeat laboratory testing in the diagnosis of heparin-induced thrombocytopenia. International Society for Thrombosis and Hemostasis XIX Congress, Birmingham, UK, July 12-18, 2003.

Francis JL and Drexler A. Trends in incidence and diagnosis of heparin-induced thrombocytopenia at a tertiary medical center. International Society for Thrombosis and Hemostasis XIX Congress, Birmingham, UK, July 12-18, 2003.

Francis JL and Court N. Impact of reagent choice on the APTT response to argatroban. International Society for Thrombosis and Hemostasis XIX Congress, Birmingham, UK, July 12-18, 2003.

Ingersoll S, Amirkhosravi A, Amaya M, Meyer TV, Desai H and Francis JL. Platelet CD40L and CD40 enhance tumor cell-induced coagulopathy and experimental metastasis. International Society for Thrombosis and Hemostasis XIX Congress, Birmingham, UK, July 12-18, 2003.

Ingersoll S, Amirkhosravi A, Meyer T, Walker J, Amaya M and Francis JL. CD40 Deficiency is Associated with Prolonged Bleeding Time and Abnormal Clot Retraction. American Heart Association Scientific Sessions, Orlando, November 9-12, 2003.

Ingersoll S, Meyer TV, Plank DM, Amirkhosravi A and Francis JL. Identification of a tissue factor ortholog in zebrafish, a potential new animal model of hemostasis and cancer. International Society for Thrombosis and Hemostasis XIX Congress, Birmingham, UK, July 12-18, 2003.

Langer F, Amirkhosravi A, Meyer T, Eifrig B, Fiedler W, Hossfeld DK and Francis JL. An in vitro study on the mechanisms of coagulation activation in acute myelogenous leukemia (AML): Role of Tissue Factor (TF) regulation by calcium ionophore, American Society for Hematology, San Diego, CA, December 6-9, 2003. Read this abstract.

Siddiqui FA, Desai H, Amirkhosravi A, Siddiqui TF, Meyer TV, Amaya M, Ahmad S and Francis JL. Tissue factor is present in platelet-derived microparticles from healthy donors. International Society for Thrombosis and Hemostasis XIX Congress, Birmingham, UK, July 12-18, 2003.

Siddiqui FA, Desai H, Siddiqui TF and Francis JL. Platelet purified vascular endothelial growth factor-165 enhances tumor cell tissue factor expression and procoagulant activity. International Society for Thrombosis and Hemostasis XIX Congress, Birmingham, UK, July 12-18, 2003.

Siddiqui FA, Desai H, Amirkhosravi A, Siddiqui TF, Meyer T, Amaya M, Amhad S and Francis JL. Functionally active tissue factor is present in platelet-derived microparticles from normal donors. American Heart Association Scientific Sessions, Orlando, November 9-12, 2003.

Siddiqui FA, Siddiqui TF and Francis JL. Hemoglobin induces the production and release of matrix metalloproteinase-9 from human malignant cells. International Society for Thrombosis and Hemostasis XIX Congress, Birmingham, UK, July 12-18, 2003.

2002

Palmer GJ, Francis JL, Drexler A and Moroose R. Comparative effects of bovine and porcine heparin on heparin antibody formation following cardiovascular surgery. Society for Thoracic Surgery 2002 Annual Meeting, Fort Lauderdale, FL, January 26-29, 2002. Read this abstract.

Francis JL, Drexler, A, Moroose R and Palmer GJ. Effect of heparin type and use of off-pump surgery on heparin-platelet factor 4 antibody formation following coronary artery bypass. Nottingham Platelet Conference (Incorporating the 5th UK Meeting on Platelets and the 9th Erfurt Meeting on Platelets), Nottingham, England, July 28-31, 2002. Read this abstract.

Siddiqui FA, Desai H, Amirkhosravi A, Amaya M, Meyer T and Francis JL. Tissue factor is present in human platelets and in platelet-derived microparticles. Nottingham Platelet Conference (Incorporating the 5th UK Meeting on Platelets and the 9th Erfurt Meeting on Platelets), Nottingham, England, July 28-31, 2002. Read this abstract.

Siddiqui FA, Siddiqui TF and Francis JL. Hemoglobin induced matrix metalloproteinase-9 release in human tumor cells is mediated by tyrosine kinase and mitogen activated protein kinase signaling pathways. Proteases, Extracellular Matrix and Cancer - an American Association for Cancer Research Special Conference in Cancer Research, Hilton Head Island, SC, October 9-13, 2002. Read this abstract.

Francis JL and Drexler A. Frequency of Heparin-Platelet Factor 4 antibodies in patients presenting to the Emergency Room with symptoms of thrombosis. American Society for Hematology, Philadelphia, PA, December, 2002. Read this abstract.

Siddiqui FA, Desai H, Amirkhosravi A, Siddiqui TF, Meyer TF, Amaya M and Francis JL. Platelet microparticles from healthy donors contain Tissue Factor. American Society for Hematology, Philadelphia, PA, December, 2002. Read this abstract.

2001

Francis JL, Drexler A, Moroose R and Palmer G. Heparin antibody formation following cardiovascular surgery. International Society for Thrombosis and Haemostasis. Paris, July 6-12, 2001.

Amirkhosravi A, Amaya M, Siddiqui F, Meyer T and Francis JL. CD40 Ligand from activated platelets enhances Tissue Factor (TF) activity of melanoma cells. International Society for Thrombosis and Haemostasis. Paris, July 6-12, 2001.

Amirkhosravi A, Meyer T, Chang JY, Amaya M, Siddiqui F, Biggerstaff J., Desai H., and Francis JL. Tissue factor pathway inhibitor reduces experimental lung metastasis of B16 melanoma. International Society for Thrombosis and Haemostasis. Paris, July 6-12, 2001.

Amirkhosravi A, Francis JL and Mousa S. The anti-metastatic effect of low molecular weight heparin (LMWH) Tinzaparin and tissue factor pathway inhibitor (TFPI). International Society for Thrombosis and Haemostasis. Paris, July 6-12, 2001.

Siddiqui FA, Amirkhosravi A and Francis JL. Vascular endothelial growth factor forms a complex with Tissue Factor. International Society for Thrombosis and Haemostasis. Paris, July 6-12, 2001.

Siddiqui FA and Francis JL. Hemoglobin induces vascular endothelial growth factor release from human malignant cells. International Society for Thrombosis and Haemostasis. Paris, July 6-12, 2001.

Siddiqui FA, Desai H, Amaya M, Amirkhosravi A, Meyer T and Francis JL. Activated human platelets express and release Tissue Factor in vitro. International Society for Thrombosis and Haemostasis. Paris, July 6-12, 2001.

Siddiqui FA and Francis JL. Identification and purification of multiple isoforms of vascular endothelial growth factor from human platelets. International Society for Thrombosis and Haemostasis. Paris, July 6-12, 2001.

Amirkhosravi A, Jiao J, Amaya M, Meyer T and Francis JL. The suppression of tumor cell procoagulant activity, experimental metastasis and primary tumor growth by monoclonal antibodies against tissue factor. International Society for Thrombosis and Haemostasis. Paris, July 6-12, 2001.

Amirkhosravi A, Mousa S, Amaya M, Blaydes S, Desai H, Meyer T and Francis JL. The oral GpIIb/IIIa antagonist (XV454) inhibits tumor cell-induced platelet aggregation in vivo and suppresses experimental lung metastasis. American Society for Hematology, 43rd Annual Meeting, Orlando, FL, December 7-11, 2001.

Siddiqui F and Francis JL. Purification and partial characterization of multiple isoforms of vascular endothelial growth factor from human platelets. American Society for Hematology, 43rd Annual Meeting, Orlando, FL, December 7-11, 2001.

Siddiqui F and Francis JL. Hemoglobin induces the release of vascular endothelial growth factor from human malignant cells. American Society for Hematology, 43rd Annual Meeting, Orlando, FL, December 7-11, 2001.

Francis JL, Drexler A, Moroose R and Palmer G. Comparative effects of bovine and porcine heparin on heparin antibody formation following cardiovascular surgery. American Society for Hematology, 43rd Annual Meeting, Orlando, FL, December 7-11, 2001.

Amirkhosravi A, Meyer T, Desai H, Amaya M, Meyer J, Barranco J and Francis JL. TFPI carboxy-terminal peptide exhibits anticoagulant activity and suppresses proliferation of melanoma and endothelial cells. American Society for Hematology, 43rd Annual Meeting, Orlando, FL, December 7-11, 2001.

Siddiqui F, Desai H, Amaya M, Amirkhosravi A and Francis JL. The presence and release of tissue factor from human platelets. American Society for Hematology, 43rd Annual Meeting, Orlando, FL, December 7-11, 2001.

2000

Amirkhosravi A, Amaya M and Francis JL. CD40 ligand (CD40L) from activated platelets induces tissue factor expression in monocytes in vitro. Platelets 2000 Symposium, Ma’ale Hachamisha, Israel, May 18-22, 2000.

Francis JL and Drexler A. Heparin antibody formation and heparin-induced thrombocytopenia following cardiovascular surgery. American Society of Hematology, 42nd Annual Meeting, San Francisco, December 1-5, 2000.

Siddiqui F and Francis JL. Vascular endothelial growth factor binds tissue factor and enhances its procoagulant activity. American Society of Hematology, 42nd Annual Meeting, San Francisco, December 1-5, 2000.

Amirkhosravi A, Amaya M and Francis JL. CD40 ligand (CD40L) from activated platelets induces tissue factor expression in monocytes. American Society of Hematology, 42nd Annual Meeting, San Francisco, December 1-5, 2000.

Amirkhosravi A, Meyer T, Chang J-Y, Amaya M, Siddiqui F, Biggerstaff JP, Desai H and Francis JL. Tissue factor pathway inhibitor reduces experimental lung metastasis on B16 melanoma. American Society of Hematology, 42nd Annual Meeting, San Francisco, December 1-5, 2000.

Lwaleed BA, Francis JL and Chisholm M. Urinary tissue factor levels in patients with bladder and prostate cancer. Eur J Surg Oncol 26: 44-49, 2000.

Lwaleed BA, Francis JL and Chisholm M. Urinary tissue factor levels in neoplastic diseases. Ann Saudi Med. 20:197-201, 2000.

1999

Francis JL. The Platelet Function Analyzer (PFA)-100Ò test in patients undergoing heart valve replacement. International Society for Thrombosis and Hemostasis, Washington, D.C., August 1999.

Amirkhosravi A, Amaya M, Siddiqui F, Biggerstaff JP, Meyer TV and Francis JL. Blockade of GpIIb/IIIa inhibits release of vascular endothelial growth factor (VEGF) from tumor cell-activated platelets and experimental metastasis. International Society for Thrombosis and Hemostasis, Washington, D.C., August 1999.

Amirkhosravi A, Amaya M, Siddiqui F, Olvey K, Meyer TV and Francis JL. Lisofylline downregulates tumor cell tissue factor expression and VEGF release and inhibits tumor cell-induced thrombocytopenia. International Society for Thrombosis and Hemostasis, Washington, D.C., August 1999.

Amirkhosravi A, Amaya M, Olvey K and Francis JL. Inhibition of LPS-induced monocyte tissue factor activity and antigen by lisofylline. International Society for Thrombosis and Hemostasis, Washington, D.C., August 1999.

Siddiqui F, Amirkhosravi A, Amaya M, Meyer TV Biggerstaff JP, and Francis JL. Purification and properties of human malignant cell tissue factor. International Society for Thrombosis and Hemostasis, Washington, D.C., August 1999.

Siddiqui F and Francis JL. Tissue factor forms a complex with hemoglobin. International Society for Thrombosis and Hemostasis, Washington, D.C., August 1999.

Siddiqui F, Amirkhosravi A, Amaya M, Biggerstaff JP, Meyer TV and Francis JL. Hemoglobin enhances tissue factor expression on human malignant cells. International Society for Thrombosis and Hemostasis, Washington, D.C., August 1999.

Francis JL. Performance of the Platelet Function Analyzer (PFA)-100Ò in clinical practice. International Society for Thrombosis and Hemostasis, Washington, D.C., August 1999.

Biggerstaff JP, Zarikian A, Janarious D, Radi M, Amirkhosravi A. and Francis JL. Quantitative analysis of procoagulant and fibrinolytic protein distribution in malignant and non-malignant tissue using three-dimensional confocal microscopy. International Society for Thrombosis and Hemostasis, Washington, D.C., August 1999.

Meyer T, Amirkhosravi A, Andrews M, Siddiqui F, Amaya M, Rogers M and Francis JL. Factor VII derived from culture media promotes adhesion and procoagulant activity in A375 human malignant melanoma cells. International Society for Thrombosis and Hemostasis, Washington, D.C., August 1999.

Biggerstaff JP, Seth NB, Amirkhosravi A, Fogarty S, Amaya M and Francis JL. Soluble fibrin mediates platelet–tumor cell binding and carries active thrombin. International Society for Thrombosis and Hemostasis, Washington, D.C., August 1999.

Biggerstaff JP, Janarious D, Gutierrez C, Radi M and Francis JL. Quantitative measurement of von Willebrand factor (vWF) in human non-malignant and malignant tissue using confocal laser scanning microscopy (CLSM). International Society for Thrombosis and Hemostasis, Washington, D.C., August 1999.

Meyer T, Amirkhosravi A, Amaya M, Siddiqui F, Rogers M and Francis JL. Glu-plasminogen induces VEGF expression in J82 human bladder carcinoma and A375 human malignant melanoma cells. International Society for Thrombosis and Hemostasis, Washington, D.C., August 1999.

Siddiqui F, Amirkhosravi A, Amaya M, Meyer T, Biggerstaff JP and Francis JL. Hemoglobin upregulates tissue factor expression on human malignant cells. American Society of Hematology, 41st Annual Meeting, New Orleans, December 3-7, 1999.

Siddiqui F and Francis JL. Enhancement of tissue factor procoagulant activity by binding to hemoglobin. American Society of Hematology, 41st Annual Meeting, New Orleans, December 3-7, 1999

Amirkhosravi A, Amaya M, Biggerstaff JP, Siddiqui F, Meyer T and Francis JL. Activated platelets and TNFa induce tissue factor (TF) expression on A375 human melanoma cells. American Society of Hematology, 41st Annual Meeting, New Orleans, December 3-7, 1999.

Francis JL. Clinical experience with the Platelet Function Analyzer (PFA)-100. American Society of Hematology, 41st Annual Meeting, New Orleans, December 3-7, 1999.

1998

Amirkhosravi A, Meyer T, Warnes G, Malik Z, Biggerstaff J, Sherman P and Francis JL. Pentoxifylline inhibits hypoxia-induced upregulation of tumor cell tissue factor activity and VEGF release. Vascular Biology 1998, San Francisco, CA, April 15-18, 1998.

Francis JL, Francis DA, Garcia M, Helms E and Larson L. Can the PFA-100 replace the bleeding time in routine clinical practice? 32nd Annual Penner Blood Coagulation Conference, Las Vegas, May 9-15, 1998.

Biggerstaff JP, Seth N, Fogarty S, Amirkhosravi S, Siddiqui F and J.L. Francis. Involvement of platelet GpIIb/IIIa (CD41) in the enhancement of platelet adherence to tumor cells by soluble fibrin. International Fibrinogen Workshop, Cleveland, August 1998.

Biggerstaff JP, Seth N, Fogarty S, Amirkhosravi S, Meyer TV and J.L. Francis. Soluble fibrin increases platelet adherence to tumor cells in vivo, and enhances experimental metastasis. International Fibrinogen Workshop, Cleveland, August 1998.

Biggerstaff JP and J.L. Francis. Enumeration of leukocyte infiltration into solid tumors by confocal laser scanning microscopy. VII International Congress of the Metastasis Research Society. San Diego, CA, October 7-10, 1998.

Amirkhosravi A, Biggerstaff JP, Meyer T, Amaya M and Francis JL. Induction of apoptosis by concanavalin A increases tumor cell tissue factor expression. VII International Congress of the Metastasis Research Society. San Diego, CA, October 7-10, 1998.

Francis JL, Francis DA, Larson L, Helms E and M. Garcia. Comparison of the Platelet Function Analyzer (PFA)-100 and template bleeding time in clinical practice. 40th Annual Meeting of the American Society for Hematology, Miami Beach, FL, December 4-8, 1998.

Amirkhosravi A, Amaya M, Biggerstaff JP, Siddiqui F, Meyer T and Francis JL. Platelet binding to A375 melanoma cells releases vascular endothelial growth factor (VEGF) from platelets. 40th Annual Meeting of the American Society for Hematology, Miami Beach, FL, December 4-8, 1998.

Siddiqui F, Amirkhosravi A, Amaya M, Meyer T, Biggerstaff JP and Francis JL. Purification and characterization of tissue factor from human melanoma cells. 40th Annual Meeting of the American Society for Hematology, Miami Beach, FL, December 4-8, 1998.

Biggerstaff JP, Seth N, Amirkhosravi A, Fogarty S, Amaya M and Francis JL. Mechanism of soluble fibrin augmentation of platelet-tumor cell adherence. 40th Annual Meeting of the American Society for Hematology, Miami Beach, FL, December 4-8, 1998.

1997

Biggerstaff JP, Amirkhosravi A and Francis JL. Relationship of coagulation and fibrinolytic proteins to angiogenesis studied by confocal laser scanning microscopy. Vascular Biology ’97. New Orleans, April 3-6, 1997.

Rajaguru JM, Biggerstaff J, Yamamoto Y, Freidman H, Francis JL and Muszynski MJ. Rotation series imaging of attachment and entry of Pseudomonas aeroginosa to rat alveloar macrophages as studied by confocal laser scanning microscopy (CLSM). Experimental Biology ’97. April 4, 1997.

Sheppard J, Biggerstaff JP, Amirkhosravi A, Cunningham G and Francis JL. Fluorescence and antitumor activities of novel pyrroles on melanoma and colon carcinoma cells. 20th Annual Research Meeting of the American Cancer Society, Florida Division Inc., Orlando, April 5, 1997.

Amirkhosravi A, Warnes G, Malik Z, Meyer T, Biggerstaff JP and Francis JL. Hypoxia causes upregulation of tissue factor and down-regulation of urokinase plasminogen activator receptor (uPAR) in A375 human melanoma cells. 20th Annual Research Meeting of the American Cancer Society, Florida Division Inc., Orlando, April 5, 1997.

Amirkhosravi A, Warnes G, Biggerstaff JP, Malik Z and Francis JL. Increase of tumor cell tissue factor expression following induction of apoptosis by concanavalin A. 20th Annual Research Meeting of the American Cancer Society, Florida Division Inc., Orlando, April 5, 1997.

Warnes G, Amirkhosravi A, Biggerstaff JP and Francis JL. Comparative detection of early and late apoptosis in human A375 melanoma cells induced by concanavalin A. 20th Annual Research Meeting of the American Cancer Society, Florida Division Inc., Orlando, April 5, 1997.

Biggerstaff, JP, Amirkhosravi A and Francis JL. Three-dimensional quantitation of tumor microvessel density by confocal laser scanning microscopy. 10th International Conference on 3D Image Processing in Microscopy and the 9th International Conference on Confocal Microscopy. Buffalo, April 27-30, 1997.

Rajaguru JM, Yamamoto Y, Biggerstaff J, Francis JL, Freidman H, and Muszynski MJ. Comparison of uptake and intracellular response of activated alveolar macrophages to L. pneuphilia and P. aeroginosa. 97th Meeting of the American Society for Microbiology. Miami Beach, Florida. May 4-8, 1997.

Amirkhosravi A, Warnes G, Biggerstaff JP, Malik Z and Francis JL. Increase of tumor cell tissue factor expression following induction of apoptosis by concanavalin A. XVI Congress of the International Society on Thrombosis and Hemostasis. Florence, June 6-12, 1997.

Biggerstaff JP, Seth N, Meyer TV, Warnes G, Amirkhosravi A and Francis JL. Fibrin monomer increases platelet adherence to tumor cells: a possible role in metastasis? XVI Congress of the International Society on Thrombosis and Hemostasis. Florence, June 6-12, 1997.

Biggerstaff JP, Amirkhosravi A and Francis JL. Detection and quantitation of coagulation and fibrinolytic proteins in human tumors by confocal laser scanning microscopy. XVI Congress of the International Society on Thrombosis and Hemostasis. Florence, June 6-12, 1997.

Amirkhosravi A, Warnes G, Biggerstaff JP and Francis JL. Tumor procoagulant activity is predominantly due to tissue factor expression. XVI Congress of the International Society on Thrombosis and Hemostasis. Florence, June 6-12, 1997.

Warnes G, Biggerstaff JP and Francis JL. Platelet-monocyte binding affects monocyte adhesion during LPS stimulation: implications in monocyte flow cytometric analysis. XVI Congress of the International Society on Thrombosis and Hemostasis. Florence, June 6-12, 1997.

Warnes G, Biggerstaff JP and Francis JL. A role for the major T-cell costimulatory antigen CD28 in monocyte-platelet interaction during LPS stimulation. XVI Congress of the International Society on Thrombosis and Hemostasis. Florence, June 6-12, 1997.

Cooper AJ, Lwaleed BA, Hayes MC, Francis JL and Chisholm M. Functional and exposed tissue factor in drug resistant cancer cell lines. XVI Congress of the International Society on Thrombosis and Hemostasis. Florence, June 6-12, 1997.

1996

Meyer T, Warnes G, Biggerstaff JP, Amirkhosravi A, Cunningham G. and Francis JL. Anti-tumor effects of a fluorescent oxadiazole compound on leukemia, neuroblastoma, melanoma and colon carcinoma cells. American Cancer Society, Orlando, March 1996.

Amirkhosravi A, Warnes G, Biggerstaff JP, Malik Z, May K and Francis JL. The effect of pentoxifylline on spontaneous and experimental metastasis of the mouse neuro2A neuro-blastoma. American Cancer Society, Orlando, March 1996.

Biggerstaff JP, Amirkhosravi A, Warnes G and Francis JL. The effect of warfarin on fibrin deposition in a murine tumor model determined by quantitative confocal laser scanning microscopy. American Cancer Society, Orlando, March 1996.

Biggerstaff JP, Mynard K, Warnes G, Amirkhosravi A and Francis JL. Decreased tumor cell membrane fluidity: a possible second mechanism for combined cytokine and chemotherapy. American Cancer Society, Orlando, March 1996.

Biggerstaff JP, Warnes G, Amirkhosravi A and Francis JL. The role of coagulation and fibrinolysis in the inhibition of lymphocyte and LAK cell cytotoxicity against melanoma cells. American Cancer Society, Orlando, March 1996.

Lwaleed BA, Francis JL, Chisholm M. Urinary tissue factor levels in neoplastic disease. British Society for Hematology, Birmingham, UK., April 1996.

Yamamoto Y, Rajyaguru JM, Biggerstaff J, Francis JL and Muszynski MJ. Study of the phagocytic interaction between P. Aeruginosa and alveolar macrophages by confocal laser scanning microscopy. Cystic Fibrosis Foundation. Tenth Annual North American Conference. Orlando, October 24-27, 1996.

Warnes G, Biggerstaff JP, Francis JL. Role of immune costimulatory molecules in the induction of monocyte tissue factor by LPS. American Society for Hematology. 38th Annual Meeting, Orlando, FL, December 6-10, 1996.

Warnes G. and Francis JL. Platelet and lymphocyte cooperation controls monocyte tissue factor expression in response to LPS. American Society for Hematology. 38th Annual Meeting, Orlando, FL, December 6-10, 1996.

Warnes G, Armanious M, Biggerstaff JP, Amirkhosravi A and Francis JL. Role of tissue factor as a cytokine receptor: B7-2 costimulatory molecule controls tissue factor expression during antigen presentation. American Society for Hematology. 38th Annual Meeting, Orlando, FL, December 6-10, 1996.

Biggerstaff JP, Seth N, Meyer TV, Warnes G, Amirkhosravi A and Francis JL. Fibrin monomer increases platelet adherence to tumor cells: a possible role in metastasis? American Society for Hematology. 38th Annual Meeting, Orlando, FL, December 6-10, 1996.

Biggerstaff JP, Amirkhosravi A, Warnes G, and Francis JL. The effect of warfarin on fibrin deposition in a murine tumor model determined by quantitative confocal laser scanning microscopy. American Society for Hematology. 38th Annual Meeting, Orlando, FL, December 6-10, 1996.

Amirkhosravi A, Warnes G, Biggerstaff JP and Francis JL. Induction of apoptosis by concanavalin A in L1210 lymphoid leukemia, A375 malignant melanoma and J82 bladder carcinoma. American Society for Hematology. 38th Annual Meeting, Orlando, FL, December 6-10, 1996.

Lwaleed B, Hays M, Cooper A, Francis JL and Chisholm M. Functional and exposed tissue factor in drug resistant cancer cells. American Society for Hematology. 38th Annual Meeting, Orlando, FL, December 6-10, 1996.

Schweitzer BI, West J, Callihan D and Logan T. Application of two-dimensional homonuclear NMR experiments employing PFG excitation sculpting to the study of oligodeoxyribonucleotides in H2O. First Annual University of Texas. Medical Branch Structural Biology Symposium; Galveston, Texas; March 2, 1996.

Foti M, Marshalko S, Beardsley GP and Schweitzer B. Biophysical studies on a DNA decamer duplex containing the antiviral drug ganciclovir. Experimental Nuclear Magnetic Resonance Conference, Asilomar, CA, March 19, 1996.

Foti M, Marshalko S, Beardsley GP and Schweitzer BI. Biophysical studies on a DNA decamer duplex containing the antiviral drug ganciclovir. American Cancer Society 19th Annual Seminar of Cancer Research in Florida; Orlando, FL, March 29, 1996.

Schweitzer BI, West J, Callihan D and Logan T, Simple, distortion-free homonuclear spectra of peptides and nucleic acids in water using excitation sculpting. XVIIth International Conference on Magnetic Resonance in Biological Systems; Keystone, CO, August 18, 1996.

Kumar S, Reed M, Gamper H, Gorn V, Lukhtanov E, Kutyavin I, Meyer R and Schweitzer BI. Solution NMR studies on novel oligonucleotide conjugates. XVIIth International Conference on Magnetic Resonance in Biological Systems; Keystone, CO, August 20, 1996.

1995

Francis JL, Francis DA and Palmer JD. Aprotinin reduces blood loss during intracranial surgery for meningioma. XVth Congress of the International Society of Thrombosis and Haemostasis, Jerusalem, Israel, June 1995.

Amirkhosravi A, Alexander A, Warnes G, Biggerstaff JP, May K, Francis DA and Francis JL. Effect of platelet activation on monocyte tissue factor expression measured by a new whole blood flow cytometric assay in whole blood. Disorders of Thrombosis and Hemostasis. North American State of the Art Consensus Update 1995. Inaugural Meeting of the International Academy of Clinical and Applied Thrombosis/Hemostasis. Dallas, November 17 and 19, 1995.

Amirkhosravi A, Alexander M, Warnes G, Biggerstaff JP, May K, Francis DA and Francis JL. Importance of platelets in expression of monocyte tissue factor antigen measured by flow cytometry in whole blood. 37th Annual Meeting of the American Society of Hematology, Seattle, WA. December 15, 1995.